Revenue Net Income P/E P/S EBIT Dividend Stocks Market capitalization Debt Liabilities Equity AAQS Employees ROE ROA ROCE

Becton Dickinson and Co AAQS 2024

Becton Dickinson and Co AAQS

Ticker

BDX

ISIN

US0758871091

WKN

857675

Revenue Net Income P/E P/S EBIT Dividend Stocks Market capitalization Debt Liabilities Equity AAQS Employees ROE ROA ROCE

Becton Dickinson and Co has a current AAQS of 7.

A high AAQS can be seen as a positive indicator that the company is developing successfully.

Investors can assume that the company is on a good path to generate profits.

On the other hand, it is important to consider the AAQS of the stock Becton Dickinson and Co in comparison to the profits generated and other companies in the same industry. A high AAQS is not an absolute guarantee for a positive future. Only in this way can one get a complete picture of the company's performance.

In order to better assess the company's development, it is important to consider the AAQS in comparison to other companies in the same industry. In general, investors should always consider the AAQS of a company in connection with other fundamentals such as profit, EBIT, cash flow, and others in order to make an informed investment decision.

Becton Dickinson and Co Aktienanalyse

What does Becton Dickinson and Co do?

Becton Dickinson and Co (BD) is an American company specializing in medical devices and accessories. It was founded in 1897 in New Jersey and since then has had a long history as an innovator in the healthcare industry. BD's business model is to manufacture and distribute medical devices and accessories for various applications. The company offers a wide range of products, including syringes, needles, catheters, infusion sets, blood diagnostic products, serum samples, tumor analysis devices, sterilization equipment, and more. BD is also a major provider of medical devices and accessories for diabetes management, including insulin pumps, lancets, test strips, and other products. BD operates in three main segments: Medical Devices, Diagnostics, and Life Sciences. In the Medical Devices segment, BD develops, manufactures, and distributes medical products such as syringes, needles, catheters, implants, and surgical instruments. This segment accounts for the largest portion of revenue, as BD's products are widely used in hospitals and other medical facilities worldwide. In the Diagnostics segment, BD offers products and services for the diagnosis of various diseases, particularly in the field of infectious diseases. Here, the company is a leader in the development of tests and instruments for the detection of HIV, hepatitis B and C, tuberculosis, and other infections. BD's Life Sciences segment produces and distributes devices and reagents for research and development, particularly in the areas of cell analysis, genomics, and proteomics. The company works closely with academics, researchers, and the pharmaceutical industry to develop innovative solutions that can contribute to the discovery of new therapies. BD is known for its long-standing experience in healthcare, its deep industry knowledge, and its efforts to develop new technologies and products that can improve people's lives. BD's products are manufactured and distributed in the United States and in more than 50 countries worldwide. Some of BD's most popular products include insulin pumps, syringes and needles, automated infusion systems, blood testing materials, and tumor diagnosis devices. In recent times, due to the pandemic, BD has also invested heavily in the development of test kits and protective clothing, thereby adapting part of its business model to the COVID-19 crisis. Overall, BD is a leading company in the medical and healthcare industry, characterized by its long history, comprehensive range of medical devices, and innovative power. With a strong focus on quality and customer satisfaction, BD remains an important provider of healthcare products and services in the healthcare industry. Becton Dickinson and Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Frequently Asked Questions about Becton Dickinson and Co stock

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Becton Dickinson and Co stock can be added to a savings plan with the following providers: Trade Republic and ING

Andere Kennzahlen von Becton Dickinson and Co

Our stock analysis for Becton Dickinson and Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Becton Dickinson and Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.